Relay Therapeutics (RLAY) Asset Utilization Ratio (2021 - 2026)
Relay Therapeutics (RLAY) posted quarterly Asset Utilization Ratio of 0.02 for Q1 2026, up 75.85% year-over-year from 0.01 in Q1 2025, and down 32.03% quarter-over-quarter from 0.02 in Q4 2025.
Powered by 
Analysis
Relay Therapeutics (RLAY) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has reported Asset Utilization Ratio for 6 consecutive years, with 0.02 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 75.85% year-over-year to 0.02; the TTM figure through Mar 2026 stood at 0.02 (up 75.85% YoY), while the FY2025 annual figure was 0.02, up 76.33% from the prior year.
- Asset Utilization Ratio slipped to 0.02 in Q1 2026 per RLAY's latest filing, from 0.02 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.04 in Q2 2024 and bottomed at 0.0 in Q2 2023.
- Historically, Asset Utilization Ratio has averaged 0.01 across 5 years, with a median of 0.01 in 2024.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio plunged 79.72% — and 2024, when it jumped 4530.49%.
- Relay Therapeutics' Asset Utilization Ratio stood at 0.0 in 2022, then jumped by 2296.6% to 0.03 in 2023, then slumped by 61.93% to 0.01 in 2024, then soared by 114.07% to 0.02 in 2025, then slumped by 32.03% to 0.02 in 2026.
- Business Quant data shows RLAY's Asset Utilization Ratio at 0.02 in Q1 2026, 0.02 in Q4 2025, and 0.01 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Relay Therapeutics | 3.87 Bn | 3.87 Bn | - | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 4.58 |